Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5% of people over 40. The high prevalence of smoldering multiple myeloma has implications for future treatment policies in multiple myeloma because people with this precursor condition, in cases where it has a high chance of developing into malignant multiple myeloma, will probably be invited to start drug treatment in the next few years. The results of the study were recently published in Nature Medicine. See further.
Dr. Kristinsson receives a large project grant from the Icelandic Centre for Research for the next three years
January 15, 2022
Sigurður Yngvi Kristinsson, principal investigator of iStopMM, received a large project grant from the Icelandic Centre for Research (RANNIS) for the next three years for
